Abstract

Bacteriophages are highly abundant in human microbiota where they coevolve with resident bacteria. Phage predation can drive the evolution of bacterial resistance, which can then drive reciprocal evolution in the phage to overcome that resistance. Such coevolutionary dynamics have not been extensively studied in human gut bacteria, and are of particular interest for both understanding and eventually manipulating the human gut microbiome. We performed experimental evolution of an Enterococcus faecium isolate from healthy human stool in the absence and presence of a single infecting Myoviridae bacteriophage, EfV12-phi1. Four replicates of E. faecium and phage were grown with twice daily serial transfers for 8 days. Genome sequencing revealed that E. faecium evolved resistance to phage through mutations in the yqwD2 gene involved in exopolysaccharide biogenesis and export, and the rpoC gene which encodes the RNA polymerase β’ subunit. In response to bacterial resistance, phage EfV12-phi1 evolved varying numbers of 1.8 kb tandem duplications within a putative tail fiber gene. Host range assays indicated that coevolution of this phage-host pair resulted in arms race dynamics in which bacterial resistance and phage infectivity increased over time. Tracking mutations from population sequencing of experimental coevolution can quickly illuminate phage entry points along with resistance strategies in both phage and host – critical information for using phage to manipulate microbial communities.

Highlights

  • Bacteriophages drive microbial diversity and function at both broad (Bouvier and Giorgio, 2007) and fine scales (Mcshan et al, 2016) through their influences on bacterial community composition (Stern et al, 2012) and bacterial pathogenesis (Davis et al, 2000)

  • Coevolution Between Enterococcus faecium and a Lytic Phage experiments that investigate the molecular interactions between phage and bacteria

  • Before phage-based therapies can be developed, we must have a solid understanding of how a targeted bacterial pathogen may evolve resistance to a treatment phage, and how the treatment phage responds to host resistance

Read more

Summary

Introduction

Bacteriophages (phages) drive microbial diversity and function at both broad (Bouvier and Giorgio, 2007) and fine scales (Mcshan et al, 2016) through their influences on bacterial community composition (Stern et al, 2012) and bacterial pathogenesis (Davis et al, 2000). Phages are estimated to be present at 109 virions per gram in the gut (Kim et al, 2011) and are likely to have major influences on beneficial and pathogenic gut bacteria. Phages that lyse their host (lytic phages) or alter host virulence gene expression (some temperate phages) present a potentially rich pool of new therapies against antibiotic resistant pathogens (Wright et al, 2009; Oechslin et al, 2016). Coevolution Between Enterococcus faecium and a Lytic Phage experiments that investigate the molecular interactions between phage and bacteria. Cocktails of multiple phages with orthogonal infection mechanisms hold great promise as therapeutics (Yen et al, 2017; Nale et al, 2018)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call